Table 2.
UniProt Accession |
Description and Gene name | Abundance Ratio: (auranofin treatment)/(negative control) | Abundance Ratio: (xanthine/xanthine oxidase treatment)/(negative control) | Abundance Ratio: (auranofin treatment)/(PBS treatment) | Abundance Ratio: (xanthine/xanthine oxidase treatment)/(PBS treatment) |
---|---|---|---|---|---|
Q13813-3a | Isoform 3 of Spectrin alpha chain, non-erythrocytic 1 SPTAN1 | 100 | 100 | 2.063 | 100 |
H3BSK9 | Ataxin-2-like protein (Fragment) ATXN2L |
100 | 0.01 | 100 | 0.01 |
Q562R1a | Beta-actin-like protein 2 ACTBL2 | 100 | 100 | 3.384 | 100 |
K7EJH8a | Alpha-actinin-4 (Fragment) ACTN4 | 100 | 100 | 2.602 | 2.855 |
O43818a | U3 small nucleolar RNA-interacting protein 2 RRP9 |
100 | 100 | 2.36 | 6.889 |
Q9BPX5 | Actin-related protein 2/3 complex subunit 5-like protein ARPC5L |
100 | 100 | 1.779 | 1.553 |
F8WBT5a | PIN2/TERF1-interacting telomerase inhibitor 1 PINX1 | 100 | 100 | 100 | 100 |
Q9NVP1a | ATP-dependent RNA helicase DDX18 DDX18 |
100 | 100 | 100 | 100 |
P55769 | NHP2-like protein 1 NHP2L1 | 100 | 1 | 100 | 3.302 |
C9JH19 | Cathepsin D light chain (Fragment) CTSD |
100 | 100 | 100 | 1 |
O15042 | U2 snRNP-associated SURP motif-containing protein U2SURP | 100 | 100 | ||
P31944 | Caspase-14 CASP14 |
100 | 0.01 | 3.616 | |
F8VS07 | LIM domain and actin-binding protein 1 LIMA1 |
100 | 100 | 2.921 | |
P04083 | Annexin A1 ANXA1 |
100 | 100 | ||
P06396 | Gelsolin GSN |
100 | 100 | 100 | |
Q9NZR1 | Tropomodulin-2 TMOD2 |
100 | 100 | ||
Q9NP55 | BPI fold-containing family A member 1 BPIFA1 |
100 | 100 | ||
Q53RT3 | Retroviral-like aspartic protease 1 ASPRV1 |
100 | 100 | ||
Q08188 | Protein-glutamine gamma-glutamyltransferase E TGM3 | 0.01 | 100 | 100 |
Six potential Prdx2 interactor candidates marked with an asterisk are upregulated in both H2O2 elevating conditions.